Immunomodulation by viruses: the myxoma virus story

被引:110
作者
Nash, P
Barrett, J
Cao, JX
Hota-Mitchell, S
Lalani, AS
Everett, H
Xu, XM
Robichaud, J
Hnatiuk, S
Ainslie, C
Seet, BT
McFadden, G
机构
[1] Robarts Res Inst, London, ON N6G 2V4, Canada
[2] Univ Western Ontario, Dept Microbiol & Immunol, London, ON, Canada
[3] Univ Alberta, Dept Biochem, Edmonton, AB, Canada
关键词
D O I
10.1111/j.1600-065X.1999.tb01286.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Myxoma virus is a poxvirus pathogen of rabbits that has evolved to replicate successfully in the presence of an active immune response by an infected host. To accomplish this, the virus has developed a variety of strategies to avoid detection by or obstruct specific aspects of the antiviral response whose consolidated action is antagonistic to virus survival. We describe two distinct viral strategies carried out by viral proteins with which myxoma virus subverts the host immune response. The first strategy is the production of virus-encoded proteins known as viroceptors or virokines that mimic host receptors or cytokines. These seek to actively block extracellular immune signals required for effective virus clearance and produce a local environment in the infected tissue that is "virus friendly". The second strategy carried out by intracellular viral proteins, seeks to retard the innate antiviral responses such as apoptosis, and kinder attempts by the infected cell to communicate with the cellular arm of the immune system. By studying these viral strategies of immune evasion, the myxoma system can provide insights into virus-host interactions and also provide new insights into the complex immune system.
引用
收藏
页码:103 / 120
页数:18
相关论文
共 118 条
[31]   The T1/35kDa family of poxvirus-secreted proteins bind chemokines and modulate leukocyte influx into virus-infected tissues [J].
Graham, KA ;
Lalani, AS ;
Macen, JL ;
Ness, TL ;
Barry, M ;
Liu, LY ;
Lucas, A ;
ClarkLewis, A ;
Moyer, RW ;
McFadden, G .
VIROLOGY, 1997, 229 (01) :12-24
[32]   MYXOMA VIRUS M11L-ORF ENCODES A PROTEIN FOR WHICH CELL-SURFACE LOCALIZATION IS CRITICAL IN MANIFESTATION OF VIRAL VIRULENCE [J].
GRAHAM, KA ;
OPGENORTH, A ;
UPTON, C ;
MCFADDEN, G .
VIROLOGY, 1992, 191 (01) :112-124
[33]   VACCINIA VIRUS HOMOLOGS OF THE SHOPE FIBROMA VIRUS INVERTED TERMINAL REPEAT PROTEINS AND A DISCONTINUOUS ORF RELATED TO THE TUMOR-NECROSIS-FACTOR RECEPTOR FAMILY [J].
HOWARD, ST ;
CHAN, YS ;
SMITH, GL .
VIROLOGY, 1991, 180 (02) :633-647
[34]   COWPOX VIRUS CONTAINS 2 COPIES OF AN EARLY GENE ENCODING A SOLUBLE SECRETED FORM OF THE TYPE-II TNF RECEPTOR [J].
HU, FQ ;
SMITH, CA ;
PICKUP, DJ .
VIROLOGY, 1994, 204 (01) :343-356
[35]   Myxoma virus in rabbits [J].
Kerr, PJ ;
Best, SM .
REVUE SCIENTIFIQUE ET TECHNIQUE-OFFICE INTERNATIONAL DES EPIZOOTIES, 1998, 17 (01) :256-268
[36]   VACCINIA VIRUS ENCODES A SECRETORY POLYPEPTIDE STRUCTURALLY RELATED TO COMPLEMENT CONTROL PROTEINS [J].
KOTWAL, GJ ;
MOSS, B .
NATURE, 1988, 335 (6186) :176-178
[37]   Functional comparisons among members of the poxvirus T1/35kDa family of soluble CC-chemokine inhibitor glycoproteins [J].
Lalani, AS ;
Ness, TL ;
Singh, R ;
Harrison, JK ;
Seet, BT ;
Kelvin, DJ ;
McFadden, G ;
Moyer, RW .
VIROLOGY, 1998, 250 (01) :173-184
[38]   The purified myxoma virus gamma interferon receptor homolog M-T7 interacts with the heparin-binding domains of chemokines [J].
Lalani, AS ;
Graham, K ;
Mossman, K ;
Rajarathnam, K ;
ClarkLewis, I ;
Kelvin, D ;
McFadden, G .
JOURNAL OF VIROLOGY, 1997, 71 (06) :4356-4363
[39]  
LALANI AS, IN PRESS VIROLOGY
[40]   CDNA SEQUENCE FOR HUMAN ERYTHROCYTE ANKYRIN [J].
LAMBERT, S ;
YU, H ;
PRCHAL, JT ;
LAWLER, J ;
RUFF, P ;
SPEICHER, D ;
CHEUNG, MC ;
KAN, YW ;
PALEK, J .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (05) :1730-1734